Brazilian Tree Compounds Show Promise in Combatting COVID-19
Scientists find natural compounds that hit COVID-19 from every angle
Science Daily
Image: Science Daily
Researchers have identified galloylquinic acids from the leaves of the Brazilian tree Copaifera lucens as potential antiviral agents against COVID-19. These compounds can block the virus's entry into cells, disrupt its replication, and reduce harmful inflammation, offering a multi-target approach that may prevent resistance development.
- 01Galloylquinic acids from Copaifera lucens can inhibit SARS-CoV-2 on multiple fronts.
- 02The compounds block viral entry, disrupt replication, and reduce inflammation.
- 03Their multi-target mechanism may reduce the likelihood of antiviral resistance.
- 04Further research is needed, including human clinical trials, before potential treatment development.
- 05The study emphasizes the importance of biodiversity in discovering new medicinal compounds.
Advertisement
In-Article Ad
A study led by Jairo Kenupp Bastos from the Ribeirão Preto School of Pharmaceutical Sciences at the University of São Paulo has revealed that galloylquinic acids, extracted from the leaves of the Copaifera lucens tree native to Brazil's Atlantic Forest, may serve as effective antiviral agents against COVID-19. These compounds exhibit a unique ability to attack SARS-CoV-2 through various mechanisms: they block the virus from entering human cells, disrupt its replication, and dampen harmful inflammation. This multi-target approach is significant as it may reduce the potential for resistance to develop, a common issue with many existing antiviral treatments that target a single viral component. The research team conducted extensive laboratory tests, including cytotoxicity assessments and plaque reduction assays, confirming the compounds' efficacy against the virus. The findings, published in *Scientific Reports*, highlight the potential of these natural compounds and underscore the importance of biodiversity in medicine. Future research will focus on testing these compounds in living organisms and initiating clinical trials to evaluate their effectiveness in humans.
Advertisement
In-Article Ad
If successful, these compounds could provide a new treatment option for COVID-19, potentially benefiting patients with severe cases and contributing to global health efforts.
Advertisement
In-Article Ad
Reader Poll
Do you believe natural compounds can effectively combat viruses like COVID-19?
Connecting to poll...
More about University of São Paulo
Read the original article
Visit the source for the complete story.




